Variable TERRA abundance and stability in cervical cancer cells

Oh,Bong-Kyeong; Keo,Ponnarath; Bae,Jaeman; Ko,Jung  Hwa; Choi,Joong  Sub

doi:10.3892/ijmm.2017.2956

Variable TERRA abundance and stability in cervical cancer cells

Authors:
- Bong-Kyeong Oh
- Ponnarath Keo
- Jaeman Bae
- Jung Hwa Ko
- Joong Sub Choi
View Affiliations

Affiliations: Institute of Medical Science, Hanyang University College of Medicine, Seoul 133-791, Republic of Korea, Department of Obstetrics and Gynecology, Hallym University Kangdong Sacred Heart Hospital, Seoul 05355, Republic of Korea
Published online on: April 20, 2017 https://doi.org/10.3892/ijmm.2017.2956
Pages: 1597-1604

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Telomeres are transcribed into long non-coding RNA, referred to as telomeric repeat-containing RNA (TERRA), which plays important roles in maintaining telomere integrity and heterochromatin formation. TERRA has been well characterized in HeLa cells, a type of cervical cancer cell. However, TERRA abundance and stability have not been examined in other cervical cancer cells, at least to the best of our knowledge. Thus, in this study, we measured TERRA levels and stability, as well as telomere length in 6 cervical cancer cell lines, HeLa, SiHa, CaSki, HeLa S3, C-33A and SNU-17. We also examined the association between the TERRA level and its stability and telomere length. We found that the TERRA level was several fold greater in the SiHa, CaSki, HeLa S3, C-33A and SNU-17 cells, than in the HeLa cells. An RNA stability assay of actinomycin D-treated cells revealed that TERRA had a short half-life of ~4 h in HeLa cells, which was consistent with previous studies, but was more stable with a longer half-life (>8 h) in the other 5 cell lines. Telomere length varied from 4 to 9 kb in the cells and did not correlate significantly with the TERRA level. On the whole, our data indicate that TERRA abundance and stability vary between different types of cervical cancer cells. TERRA degrades rapidly in HeLa cells, but is maintained stably in other cervical cancer cells that accumulate higher levels of TERRA. TERRA abundance is associated with the stability of RNA in cervical cancer cells, but is unlikely associated with telomere length.

View Figures

View References

1	Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:405–413. 1985. View Article : Google Scholar : PubMed/NCBI
2	de Lange T: Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100–2110. 2005. View Article : Google Scholar : PubMed/NCBI
3	Shay JW, Zou Y, Hiyama E and Wright WE: Telomerase and cancer. Hum Mol Genet. 10:677–685. 2001. View Article : Google Scholar : PubMed/NCBI
4	Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science. 279:349–352. 1998. View Article : Google Scholar : PubMed/NCBI
5	Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T and Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 18:65–68. 1998. View Article : Google Scholar : PubMed/NCBI
6	Palm W and de Lange T: How shelterin protects mammalian telomeres. Annu Rev Genet. 42:301–334. 2008. View Article : Google Scholar : PubMed/NCBI
7	Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E and Lingner J: Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science. 318:798–801. 2007. View Article : Google Scholar : PubMed/NCBI
8	Schoeftner S and Blasco MA: Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol. 10:228–236. 2008. View Article : Google Scholar
9	Luke B, Panza A, Redon S, Iglesias N, Li Z and Lingner J: The Rat1p 5′ to 3′ exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in Saccharomyces cerevisiae. Mol Cell. 32:465–477. 2008. View Article : Google Scholar : PubMed/NCBI
10	Vrbsky J, Akimcheva S, Watson JM, Turner TL, Daxinger L, Vyskot B, Aufsatz W and Riha K: siRNA-mediated methylation of Arabidopsis telomeres. PLoS Genet. 6:e10009862010. View Article : Google Scholar : PubMed/NCBI
11	Bah A, Wischnewski H, Shchepachev V and Azzalin CM: The telomeric transcriptome of Schizosaccharomyces pombe. Nucleic Acids Res. 40:2995–3005. 2012. View Article : Google Scholar :
12	Nergadze SG, Farnung BO, Wischnewski H, Khoriauli L, Vitelli V, Chawla R, Giulotto E and Azzalin CM: CpG-island promoters drive transcription of human telomeres. RNA. 15:2186–2194. 2009. View Article : Google Scholar : PubMed/NCBI
13	Arnoult N, Van Beneden A and Decottignies A: Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1α. Nat Struct Mol Biol. 19:948–956. 2012. View Article : Google Scholar : PubMed/NCBI
14	Porro A, Feuerhahn S, Reichenbach P and Lingner J: Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol Cell Biol. 30:4808–4817. 2010. View Article : Google Scholar : PubMed/NCBI
15	Deng Z, Wang Z, Xiang C, Molczan A, Baubet V, Conejo-Garcia J, Xu X, Lieberman PM and Dahmane N: Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma. J Cell Sci. 125:4383–4394. 2012. View Article : Google Scholar : PubMed/NCBI
16	Azzalin CM and Lingner J: Telomere functions grounding on TERRA firma. Trends Cell Biol. 25:29–36. 2015. View Article : Google Scholar
17	Yehezkel S, Segev Y, Viegas-Péquignot E, Skorecki K and Selig S: Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet. 17:2776–2789. 2008. View Article : Google Scholar : PubMed/NCBI
18	Pfeiffer V and Lingner J: TERRA promotes telomere shortening through exonuclease 1-mediated resection of chromosome ends. PLoS Genet. 8:e10027472012. View Article : Google Scholar : PubMed/NCBI
19	Redon S, Reichenbach P and Lingner J: The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 38:5797–5806. 2010. View Article : Google Scholar : PubMed/NCBI
20	Iglesias N, Redon S, Pfeiffer V, Dees M, Lingner J and Luke B: Subtelomeric repetitive elements determine TERRA regulation by Rap1/Rif and Rap1/Sir complexes in yeast. EMBO Rep. 12:587–593. 2011. View Article : Google Scholar : PubMed/NCBI
21	Farnung BO, Brun CM, Arora R, Lorenzi LE and Azzalin CM: Telomerase efficiently elongates highly transcribing telomeres in human cancer cells. PLoS One. 7:e357142012. View Article : Google Scholar : PubMed/NCBI
22	Smirnova A, Gamba R, Khoriauli L, Vitelli V, Nergadze SG and Giulotto E: TERRA expression levels do not correlate with telomere length and radiation sensitivity in human cancer cell lines. Front Oncol. 3:1152013. View Article : Google Scholar : PubMed/NCBI
23	Van Beneden A, Arnoult N and Decottignies A: Telomeric RNA expression: Length matters. Front Oncol. 3:1782013. View Article : Google Scholar : PubMed/NCBI
24	Deng Z, Wang Z, Stong N, Plasschaert R, Moczan A, Chen HS, Hu S, Wikramasinghe P, Davuluri RV, Bartolomei MS, et al: A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J. 31:4165–4178. 2012. View Article : Google Scholar : PubMed/NCBI
25	Riethman HC, Xiang Z, Paul S, Morse E, Hu XL, Flint J, Chi HC, Grady DL and Moyzis RK: Integration of telomere sequences with the draft human genome sequence. Nature. 409:948–951. 2001. View Article : Google Scholar : PubMed/NCBI
26	Riethman H, Ambrosini A, Castaneda C, Finklestein J, Hu XL, Mudunuri U, Paul S and Wei J: Mapping and initial analysis of human subtelomeric sequence assemblies. Genome Res. 14:18–28. 2004. View Article : Google Scholar : PubMed/NCBI
27	Ambrosini A, Paul S, Hu S and Riethman H: Human subtelomeric duplicon structure and organization. Genome Biol. 8:R1512007. View Article : Google Scholar : PubMed/NCBI
28	Ro-Choi TS, Raj NB, Pike LM and Busch H: Effects of alpha-amanitin, cycloheximide, and thioacetamide on low molecular weight nuclear RNA. Biochemistry. 15:3823–3828. 1976. View Article : Google Scholar : PubMed/NCBI
29	Noonberg SB, Scott GK and Benz CC: Evidence of post-transcriptional regulation of U6 small nuclear RNA. J Biol Chem. 271:10477–10481. 1996. View Article : Google Scholar : PubMed/NCBI
30	Vitelli V, Falvo P, Khoriauli L, Smirnova A, Gamba R, Santagostino M, Nergadze SG and Giulotto E: More on the lack of correlation between terra expression and telomere length. Front Oncol. 3:2452013. View Article : Google Scholar : PubMed/NCBI
31	Zhou XZ and Lu KP: The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell. 107:347–359. 2001. View Article : Google Scholar : PubMed/NCBI
32	Autexier C and Lue NF: The structure and function of telomerase reverse transcriptase. Annu Rev Biochem. 75:493–517. 2006. View Article : Google Scholar : PubMed/NCBI
33	Porro A, Feuerhahn S, Delafontaine J, Riethman H, Rougemont J and Lingner J: Functional characterization of the TERRA transcriptome at damaged telomeres. Nat Commun. 5:53792014. View Article : Google Scholar : PubMed/NCBI
34	Scheibe M, Arnoult N, Kappei D, Buchholz F, Decottignies A, Butter F and Mann M: Quantitative interaction screen of telomeric repeat-containing RNA reveals novel TERRA regulators. Genome Res. 23:2149–2157. 2013. View Article : Google Scholar : PubMed/NCBI